Application of antisense oligodeoxynucleotides (ODNs) for the intervention of kidney disease. Antisense ODNs for transforming growth factor-beta-suppressed glomerulosclerosis in experimental glomerulonephritis

Contrib Nephrol. 1996:118:86-93. doi: 10.1159/000425080.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Nucleus / metabolism
  • Glomerulonephritis / drug therapy*
  • Humans
  • Kidney Glomerulus / metabolism
  • Oligonucleotides, Antisense / metabolism
  • Oligonucleotides, Antisense / therapeutic use*
  • Protein Biosynthesis
  • RNA, Messenger / analysis
  • Transforming Growth Factor beta / genetics

Substances

  • Oligonucleotides, Antisense
  • RNA, Messenger
  • Transforming Growth Factor beta